US Anticoagulant and Antiplatelet Therapies ... - Frost & Sullivan


Dec 6, 2012 (5 years and 4 months ago)


© Copyright 2002 Frost & Sullivan. All Rights Reserved.

U.S. Anticoagulant and Antiplatelet
Therapies Markets

New Generation Therapies Signify Market Growth

"The growing patient uptake of innovative and costly anticoagulants and antiplatelets
coupled with the exploration of opportunities in under
served, niche markets, drive the
growth of the anti
clotting therapies market in the United States.”

Pharmaceutical Biotech Analyst Team

Frost & Sullivan

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Frost & Sullivan provides:

Detailed insights into recent developments and trends

Drivers, restraints, challenges, and strategic recommendations

Analyst insights on ‘hot topics’ and emerging applications

in the
anticoagulant and antiplatelet therapies


Market sizing and competitive analysis

Market forecasts and opportunity analysis

Quarterly assessments

End user analysis within each report

Key Features

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Coverage: The United States

Proven methodology encompassing extensive primary and
secondary data and research

Focused information and strategies that cover business and
technology issues

Credible data and analysis highlighting industry dynamics

Winning strategies to help you create precise business plans

What We Offer

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Current Market Participants

Find out how you compare to the competition

Assess current and future drivers and restraints

Determine and exploit new market share opportunities

New Entrants

Analyze challenges associated with the industry

Calculate time scales for strategy implementation

Position yourself to capitalize on the market’s unmet needs

Investment Community

Analyze long
term strategies of companies

Determine which participants will outperform the competition

Assess attractiveness of investing in the market

Who Will Benefit?

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Dimensional Pharmaceuticals, Inc.

Abbott Laboratories

Akzo Nobel nv

American Biogenetic Sciences

American Heart Association, Inc.

AstraZeneca Pharmaceuticals LP

Aventis Pharmaceuticals, Inc.

Berlex Laboratories, Inc.

Boehringer Ingelheim Pharmaceuticals, Inc.

Myers Squibb Co.

Centocor, Inc.

Corvas International, Inc.

Eli Lilly & Co.

Emisphere Technologies, Inc.

Eon Laboratories, Inc.


GlycoDesign, Inc.

La Jolla Pharmaceutical Co.

Merck & Co.

Millennium Pharmaceuticals, Inc.

Mitsubishi Pharma America, Inc.

Par Pharmaceutical, Inc.

Pharmacia Corp.

Roche Pharmaceuticals

Synthelabo, Inc.

Plough Corp.

Taro Pharmaceuticals USA, Inc.

Texas Biotechnology Corp.

The Medicines Co.

Yamanouchi Pharma America, Inc.

Key Market Participants

© Copyright 2002 Frost & Sullivan. All Rights Reserved.

Call toll free




Fax toll free




For More Information